{"id":1953,"date":"2024-06-10T14:50:16","date_gmt":"2024-06-10T14:50:16","guid":{"rendered":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/"},"modified":"2024-06-10T14:50:16","modified_gmt":"2024-06-10T14:50:16","slug":"fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors","status":"publish","type":"post","link":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/","title":{"rendered":"FDA approves two new Abbott over-the-counter continuous glucose monitors"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div id=\"RegularArticle-ArticleBody-5\" data-module=\"ArticleBody\" data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\"><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<div class=\"InlineImage-imageEmbed\" id=\"ArticleBody-InlineImage-106998194\" data-test=\"InlineImage\">\n<div class=\"InlineImage-wrapper\">\n<div>\n<p>Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.<\/p>\n<p>Ethan Miller | Getty Images<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"group\">\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-1\"><a href=\"https:\/\/www.cnbc.com\/quotes\/ABT\/\">Abbott Laboratories<\/a><span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> announced Monday it <a href=\"https:\/\/abbott.mediaroom.com\/2024-06-10-Abbott-Receives-U-S-FDA-Clearance-for-Two-New-Over-the-Counter-Continuous-Glucose-Monitoring-Systems\" target=\"_blank\" rel=\"noopener\">received approval<\/a> from the U.S. Food and Drug Administration for two new continuous glucose monitoring systems, including one for people who don&#8217;t have diabetes. Both will be available over the counter without a prescription.<\/p>\n<p>A continuous glucose monitor, or a CGM, is a small sensor that pokes through the skin and tracks a person&#8217;s glucose levels in real time. It wirelessly transmits this data to a smartphone. CGMs are primarily used by patients with diabetes since the tech can help alert users, their families and their doctors to emergencies.<\/p>\n<p>The market opportunity could be significant for Abbott, whose existing CGMs are already used by around 6 million patients across 60 countries, Abbot said. Around 38.4 million people are living with diabetes in the U.S. alone, Abbott said, and offering a consumer-facing CGM brings the technology to an entirely new population.<\/p>\n<p>One of Abbott&#8217;s new systems, Libre Rio, is for patients with Type 2 diabetes who do not take insulin. Its second system, Lingo, is for consumers trying to improve their health and wellness, according to <a href=\"https:\/\/abbott.mediaroom.com\/2024-06-10-Abbott-Receives-U-S-FDA-Clearance-for-Two-New-Over-the-Counter-Continuous-Glucose-Monitoring-Systems\" target=\"_blank\" rel=\"noopener\">the company<\/a>.<\/p>\n<p>Abbott said Lingo users will wear a biosensor on their upper arm for 14 days at a time, and they can track their glucose data within a coaching app on their phone. Participants get access to customized coaching based on their data that can help them &#8220;retrain their metabolism and improve their overall wellbeing,&#8221; the company said.<\/p>\n<p>Several companies like<a href=\"https:\/\/www.cnbc.com\/2024\/03\/09\/signos-review-i-learned-how-eating-and-exercise-impact-my-blood-sugar.html\"> Signos<\/a> use CGMs to help people lose weight and improve their metabolic health. Oftentimes, users need a valid CGM prescription to participate in these programs, so Abbott&#8217;s new over-the-counter offering could be more accessible for some consumers.<\/p>\n<p>Libre Rio is Abbott&#8217;s first over-the-counter offering for people with diabetes in the U.S., though other CGMs within its portfolio have been available without a prescription in other countries over the last decade. Libre Rio is designed for Type 2 patients who usually manage their diabetes with lifestyle modifications, the company said.<\/p>\n<p>Abbott competitor <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-5\"><a href=\"https:\/\/www.cnbc.com\/quotes\/DXCM\/\">Dexcom<\/a><span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span>, which also sells CGM systems, received FDA approval for its first-ever <a href=\"https:\/\/www.cnbc.com\/2024\/03\/05\/dexcom-announces-stelo-has-been-cleared-by-the-fda-.html\">over-the-counter CGM<\/a> in March.<\/p>\n<\/div>\n<div class=\"group\">\n<div class=\"RelatedContent-relatedContent\" id=\"RegularArticle-RelatedContent-1\">\n<div class=\"RelatedContent-container\">\n<div class=\"RelatedContent-nonCollapsibleContent\">\n<h2 class=\"RelatedContent-header\">Don\u2019t miss these exclusives from CNBC PRO<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.cnbc.com\/2024\/06\/10\/abbott-fda-approval-libre-rio-lingo-cgm-diabetes.html\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring&#8230;<\/p>\n<p class=\"more-link-wrap\"><a href=\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\" class=\"more-link\">Read More<span class=\"screen-reader-text\"> &ldquo;FDA approves two new Abbott over-the-counter continuous glucose monitors&rdquo;<\/span> &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":1954,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/106998194-1641558949731-gettyimages-1363222030-em018417_20220106104408207.jpeg?v=1718021922&w=1920&h=1080","fifu_image_alt":"","footnotes":""},"categories":[4],"tags":[1295,924,77,1296,994,70,413,252,426],"class_list":["post-1953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbott-laboratories","tag-breaking-news-technology","tag-business-news","tag-dexcom-inc","tag-enterprise","tag-health-care-industry","tag-internet","tag-technology","tag-united-states"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.8 (Yoast SEO v22.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA approves two new Abbott over-the-counter continuous glucose monitors - Breaking News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves two new Abbott over-the-counter continuous glucose monitors\" \/>\n<meta property=\"og:description\" content=\"Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring...Read More &ldquo;FDA approves two new Abbott over-the-counter continuous glucose monitors&rdquo; &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\" \/>\n<meta property=\"og:site_name\" content=\"Breaking News\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-10T14:50:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/image.cnbcfm.com\/api\/v1\/image\/106998194-1641558949731-gettyimages-1363222030-em018417_20220106104408207.jpeg?v=1718021922&w=1920&h=1080\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/image.cnbcfm.com\/api\/v1\/image\/106998194-1641558949731-gettyimages-1363222030-em018417_20220106104408207.jpeg?v=1718021922&w=1920&h=1080\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\/\/ventil.rs\/blog\/#\/schema\/person\/8b364f5cc7fbc8705a888e63db8c026a\"},\"headline\":\"FDA approves two new Abbott over-the-counter continuous glucose monitors\",\"datePublished\":\"2024-06-10T14:50:16+00:00\",\"dateModified\":\"2024-06-10T14:50:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\"},\"wordCount\":398,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ventil.rs\/blog\/#organization\"},\"keywords\":[\"Abbott Laboratories\",\"Breaking News: Technology\",\"business news\",\"Dexcom Inc\",\"Enterprise\",\"Health care industry\",\"Internet\",\"technology\",\"United States\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/ventil.rs\/blog\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\",\"url\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\",\"name\":\"FDA approves two new Abbott over-the-counter continuous glucose monitors - Breaking News\",\"isPartOf\":{\"@id\":\"https:\/\/ventil.rs\/blog\/#website\"},\"datePublished\":\"2024-06-10T14:50:16+00:00\",\"dateModified\":\"2024-06-10T14:50:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ventil.rs\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves two new Abbott over-the-counter continuous glucose monitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ventil.rs\/blog\/#website\",\"url\":\"https:\/\/ventil.rs\/blog\/\",\"name\":\"Breaking News\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ventil.rs\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ventil.rs\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ventil.rs\/blog\/#organization\",\"name\":\"Breaking News\",\"url\":\"https:\/\/ventil.rs\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ventil.rs\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ventil.rs\/blog\/wp-content\/uploads\/2023\/07\/ventilshop-2362x591-1.png\",\"contentUrl\":\"https:\/\/ventil.rs\/blog\/wp-content\/uploads\/2023\/07\/ventilshop-2362x591-1.png\",\"width\":1445,\"height\":591,\"caption\":\"Breaking News\"},\"image\":{\"@id\":\"https:\/\/ventil.rs\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ventil.rs\/blog\/#\/schema\/person\/8b364f5cc7fbc8705a888e63db8c026a\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ventil.rs\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e3dd0b52c93ce674a00a0dbe8383290fdc661c12a7e48e5953f790da3887973d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e3dd0b52c93ce674a00a0dbe8383290fdc661c12a7e48e5953f790da3887973d?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"sameAs\":[\"https:\/\/ventil.rs\/blog\"],\"url\":\"https:\/\/ventil.rs\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA approves two new Abbott over-the-counter continuous glucose monitors - Breaking News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves two new Abbott over-the-counter continuous glucose monitors","og_description":"Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring...Read More &ldquo;FDA approves two new Abbott over-the-counter continuous glucose monitors&rdquo; &raquo;","og_url":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/","og_site_name":"Breaking News","article_published_time":"2024-06-10T14:50:16+00:00","og_image":[{"url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/106998194-1641558949731-gettyimages-1363222030-em018417_20220106104408207.jpeg?v=1718021922&w=1920&h=1080"}],"author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/106998194-1641558949731-gettyimages-1363222030-em018417_20220106104408207.jpeg?v=1718021922&w=1920&h=1080","twitter_misc":{"Written by":"Admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#article","isPartOf":{"@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/"},"author":{"name":"Admin","@id":"https:\/\/ventil.rs\/blog\/#\/schema\/person\/8b364f5cc7fbc8705a888e63db8c026a"},"headline":"FDA approves two new Abbott over-the-counter continuous glucose monitors","datePublished":"2024-06-10T14:50:16+00:00","dateModified":"2024-06-10T14:50:16+00:00","mainEntityOfPage":{"@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/"},"wordCount":398,"commentCount":0,"publisher":{"@id":"https:\/\/ventil.rs\/blog\/#organization"},"keywords":["Abbott Laboratories","Breaking News: Technology","business news","Dexcom Inc","Enterprise","Health care industry","Internet","technology","United States"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/ventil.rs\/blog\/#organization"}},{"@type":"WebPage","@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/","url":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/","name":"FDA approves two new Abbott over-the-counter continuous glucose monitors - Breaking News","isPartOf":{"@id":"https:\/\/ventil.rs\/blog\/#website"},"datePublished":"2024-06-10T14:50:16+00:00","dateModified":"2024-06-10T14:50:16+00:00","breadcrumb":{"@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ventil.rs\/blog\/health\/fda-approves-two-new-abbott-over-the-counter-continuous-glucose-monitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ventil.rs\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA approves two new Abbott over-the-counter continuous glucose monitors"}]},{"@type":"WebSite","@id":"https:\/\/ventil.rs\/blog\/#website","url":"https:\/\/ventil.rs\/blog\/","name":"Breaking News","description":"","publisher":{"@id":"https:\/\/ventil.rs\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ventil.rs\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ventil.rs\/blog\/#organization","name":"Breaking News","url":"https:\/\/ventil.rs\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ventil.rs\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/ventil.rs\/blog\/wp-content\/uploads\/2023\/07\/ventilshop-2362x591-1.png","contentUrl":"https:\/\/ventil.rs\/blog\/wp-content\/uploads\/2023\/07\/ventilshop-2362x591-1.png","width":1445,"height":591,"caption":"Breaking News"},"image":{"@id":"https:\/\/ventil.rs\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ventil.rs\/blog\/#\/schema\/person\/8b364f5cc7fbc8705a888e63db8c026a","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ventil.rs\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e3dd0b52c93ce674a00a0dbe8383290fdc661c12a7e48e5953f790da3887973d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3dd0b52c93ce674a00a0dbe8383290fdc661c12a7e48e5953f790da3887973d?s=96&d=mm&r=g","caption":"Admin"},"sameAs":["https:\/\/ventil.rs\/blog"],"url":"https:\/\/ventil.rs\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/posts\/1953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/comments?post=1953"}],"version-history":[{"count":0,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/posts\/1953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/media\/1954"}],"wp:attachment":[{"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/media?parent=1953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/categories?post=1953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ventil.rs\/blog\/wp-json\/wp\/v2\/tags?post=1953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}